Related Experiment Video

Updated: Jun 7, 2026

Concurrent Collection of Fetal Murine Brain and Serum to Assess Effects of Maternal Diet on Nutrition and Neurodevelopment in Neurofibromatosis Type 1
05:44

Concurrent Collection of Fetal Murine Brain and Serum to Assess Effects of Maternal Diet on Nutrition and Neurodevelopment in Neurofibromatosis Type 1

Published on: May 17, 2024

Prepregnancy obesity: a complex risk factor for selected birth defects

Suzan L Carmichael1, Sonja A Rasmussen, Gary M Shaw

  • 1California Research Division, March of Dimes Foundation, 5700 Martin Luther King, Jr. Way, Oakland, CA 94609, USA. scarmichael@marchofdimes.com

Birth Defects Research. Part A, Clinical and Molecular Teratology
|October 26, 2010
PubMed

Insights

Maternal obesity increases risks for adverse pregnancy outcomes and birth defects. Understanding the mechanisms behind this association is crucial for developing effective public health strategies.

Area of Science:

  • Reproductive Health
  • Developmental Biology
  • Public Health

Background:

  • Obesity is linked to numerous health issues.
  • Maternal obesity poses significant risks during pregnancy for both mother and child.
  • Emerging research highlights a connection between pre-pregnancy weight and birth defect risks.

Purpose of the Study:

  • To review the existing literature on the association between maternal obesity and birth defects.
  • To discuss potential underlying biological and environmental mechanisms.
  • To identify research gaps and suggest future research directions.

Main Methods:

  • Literature review of studies published over the last 20 years.
  • Synthesis of evidence on maternal pre-pregnancy weight and birth defect risks.
  • Discussion of proposed mechanisms linking obesity and developmental abnormalities.

Main Results:

  • A growing body of evidence indicates an association between maternal obesity and increased risk of certain birth defects.
  • Several potential mechanisms are proposed, including altered maternal metabolism, inflammation, and nutrient deficiencies.
  • The precise pathways and contributing factors require further investigation.

Conclusions:

  • Maternal obesity is a significant risk factor for birth defects.
  • Further research into the underlying mechanisms is essential for targeted prevention strategies.
  • Public health initiatives should consider addressing pre-pregnancy weight management to mitigate risks.

More Related Videos

A Primary Human Trophoblast Model to Study the Effect of Inflammation Associated with Maternal Obesity on Regulation of Autophagy in the Placenta11:44

A Primary Human Trophoblast Model to Study the Effect of Inflammation Associated with Maternal Obesity on Regulation of Autophagy in the Placenta

Published on: September 27, 2017

Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection06:11

Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection

Published on: May 17, 2024

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Bulimia Nervosa01:30

Bulimia Nervosa

Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...